Clinical Scorecard: Building Biology, Not Just Pathology

At a Glance

Key Highlights

• AI accelerates drug development through faster compound screening and lead optimization.
• Pathologists play a critical role in linking scientific data with clinical insights and AI models.
• AI enhances biomarker discovery and patient stratification for personalized drug development.
• Digital pathology platforms are evolving to support collaboration between diagnostic labs and pharma.
• Future advancements will integrate data from various health systems to improve precision medicine.

Guideline-Based Recommendations

Diagnosis

• Utilize AI for automated quantification of histologic features.
• Ensure clinical relevance in AI model outputs.

Management

• Incorporate AI-driven analytics in clinical trial design.
• Focus on data standardization and validation for regulatory submissions.

Monitoring & Follow-up

• Regularly validate AI models against expert diagnoses.
• Ensure interpretability of AI outputs through pathologist review.

Risks

• Potential biases in AI models if not properly validated.
• Dependence on data quality for accurate AI training.

Patient & Prescribing Data

Patients with conditions such as non-small cell lung cancer and nonalcoholic steatohepatitis.

AI can identify patients likely to benefit from targeted therapies, improving clinical trial success rates.

Clinical Best Practices

• Engage pathologists in data annotation and curation for AI training.
• Develop integrated data ecosystems for comprehensive disease understanding.
• Foster real-time collaboration between research teams and diagnostic labs.

References

• DP&AI: Europe 2025 Panel Discussion